PEA & ALA IV
Natural health product licensed in Canada
- Other names
- P.E.A. k Pain Relief, P.E.A.k ALA, P.E.A.k Antioxidant Support, P.E.A.k Axon, P.E.A.k Glucose, P.E.A.k Glucose Metabolism, P.E.A.k Recovery, PEA & ALA, PEA + Alpha Lipoic Acid, Pro P.E.A.k ALA, Pro P.E.A.k Antioxidant Support, Pro PEA & ALA
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80096768
- Status
- Active licence
- Licence date
- 22 January 2020
- Revision date
- 3 February 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide 1,2-dithiolane-3-pentanoïque, (R) Source : Sodium R-(+)-Lipoate | 200 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéaryl fumarate de sodium, Poudre de racine de carotte, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Provides antioxidants. Helps to promote healthy glucose metabolism. Studies show that PEA may be used as an anti-inflammatory to help relieve pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have diabetes or if symptoms persist or worsen. If you experience sweating, paleness, chills, headache, dizziness and/or confusion, discontinue use and consult a healthcare practitioner (as these may be symptoms of serious low blood sugar).
Source
Official Health Canada record, licence 80096768
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging